Keyphrases
Intubation
100%
COVID-19 Patients
100%
C-reactive Protein
42%
In-hospital Mortality
42%
Lactate Dehydrogenase
28%
Acute Hypoxemic Respiratory Failure
28%
Chest CT
28%
Random Forest Regression
28%
Cardiovascular Disease
14%
COVID-19
14%
High Risk
14%
Clinical Variables
14%
Fibrosis
14%
Intensive Care Unit
14%
Quantitative Parameters
14%
Inspired Oxygen
14%
Arterial Oxygenation
14%
Risk Factors
14%
University Hospital
14%
Glycemia
14%
Laboratory Parameters
14%
White Blood Cell Count
14%
Computerized Tomography
14%
Symptom Onset
14%
Triage
14%
Order of Accuracy
14%
Invasive Mechanical Ventilation
14%
Tomographic Analysis
14%
Lymphocyte Count
14%
Partial Pressure
14%
Patient Demographic Characteristics
14%
Ground-glass Opacity
14%
Predictors of Adverse Outcomes
14%
Rebalance
14%
Lactate Dehydrogenase C
14%
Radiographic Predictors
14%
Haematochemical
14%
Medicine and Dentistry
Retrospective Study
100%
Intubation
100%
COVID-19
100%
Lactate Dehydrogenase
42%
Computer Assisted Tomography
42%
C Reactive Protein
42%
Hospital Mortality
42%
Acute Respiratory Failure
28%
Sphingolipid Activator Protein 2
28%
Cardiovascular Disease
14%
Clinician
14%
Intensive Care Unit
14%
Deterioration
14%
Fraction of Inspired Oxygen
14%
Cell Count
14%
Leukocyte
14%
Fibrosis
14%
Triage
14%
Artificial Respiration
14%
Adverse Outcome
14%
Ground Glass Opacity
14%
Lymphocyte
14%
Nursing and Health Professions
Intubation
100%
C Reactive Protein
42%
Hospital Mortality
42%
Computer Assisted Tomography
42%
Lactate Dehydrogenase
42%
Acute Respiratory Failure
28%
Sphingolipid Activator Protein 2
28%
Random Forest
28%
Glucose Blood Level
14%
Triage
14%
Intensive Care Unit
14%
Artificial Respiration
14%
Partial Pressure
14%
Cardiovascular Disease
14%
University Hospital
14%
Adverse Outcome
14%
Fibrosis
14%
Deterioration
14%
Lymphocyte Count
14%
Leukocyte Count
14%
Fraction of Inspired Oxygen
14%
Arterial Oxygen Tension
14%
Pharmacology, Toxicology and Pharmaceutical Science
Intubation
100%
Retrospective Study
100%
Lactate Dehydrogenase
42%
C Reactive Protein
42%
Hospital Mortality
42%
Acute Respiratory Failure
28%
Sphingolipid Activator Protein 2
28%
Fibrosis
14%
Adverse Outcome
14%
Deterioration
14%
Cardiovascular Disease
14%